StreetInsider.com News Articles

VSee Health expands hospital network to 58 locations, reports revenue growth

Thu, 25 Jun 2026 08:32:12 -0400

VSee Health, Inc. (NASDAQ: VSEE) announced that its hospital network has grown to 58 locations, up from 3 approximately two years ago, according to a press release from the Houston-based company.

The company reported revenue of $11.4 million in 2025, reflecting growth of more than 80% compared to the prior year. VSee Health attributed the network expansion to growth in Integrated Delivery Network relationships and multi-year deployments.

Dr. Imoigele Aisiku, Chairman and Chief Executive Officer, stated, "We have become a pure-play enterprise telehealth provider and are at a major inflection point having reached 58 hospitals. We expect to continue to expand our

VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations

Thu, 25 Jun 2026 08:30:00 -0400

Key Driver for its Enterprise Telehealth Revenue Acceleration

HOUSTON, TX / ACCESS Newswire / June 25, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, is pleased to announce that its hospital footprint has grown to 58 locations, up from just 3 in approximately two tears. This dramatic ramp of 20-fold over the past two years, has led to a significant +80% growth in revenue in 2025 to $11.4 million.

This growth in the VSee hospital network has been driven by expanding Integrated

VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations

Thu, 25 Jun 2026 08:30:00 -0400

Key Driver for its Enterprise Telehealth Revenue Acceleration

This growth in the VSee hospital network has been driven by expanding Integrated

VSee Health reports revenue growth after selling VSee Lab unit

Mon, 22 Jun 2026 08:32:03 -0400

VSee Health, Inc. (NASDAQ: VSEE) reported pro-forma revenue growth following its sale of VSee Lab on May 31, 2026, according to a company press release.

The Houston-based telehealth company said its iDoc telehealth platform and enterprise healthcare solutions segment recorded 60% revenue growth to $8 million in 2025 and 70% revenue growth to $2.5 million in the first quarter of 2026. The company also reported an approximate reduction of $6 million in annual operating expenses following the divestiture.

VSee Health said several large Integrated Health Network multi-year contracts signed throughout 2025 are continuing to roll out and add telehealth services.

Chairman and Chief

VSee Health reports revenue growth after selling VSee Lab unit

Mon, 22 Jun 2026 08:32:03 -0400

VSee Health, Inc. (NASDAQ: VSEE) reported pro-forma revenue growth following its sale of VSee Lab on May 31, 2026, according to a company press release.

VSee Health said several large Integrated Health Network multi-year contracts signed throughout 2025 are continuing to roll out and add telehealth services.

Chairman and Chief

VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale

Mon, 22 Jun 2026 08:30:00 -0400

Refocus on Telehealth and Digital Health Solutions That Provided 80% Revenue Growth in 2025

HOUSTON, TX / ACCESS Newswire / June 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solution, is pleased to provide an update on its business operations and financial success following its strategic sale of VSee Lab on May 31, 2026.

Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions:

+60% revenue growth to $8 million in 2025
+70% revenue growth to $2.5 million in Q1

VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale

Mon, 22 Jun 2026 08:30:00 -0400

Refocus on Telehealth and Digital Health Solutions That Provided 80% Revenue Growth in 2025

Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions:

+60% revenue growth to $8 million in 2025
+70% revenue growth to $2.5 million in Q1

Form 424B3 VSEE HEALTH, INC.

Thu, 11 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260611/26635762.html

Form 424B3 VSEE HEALTH, INC.

Thu, 11 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260611/26635762.html

Form 8-K VSEE HEALTH, INC. For: Jun 02

Thu, 11 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260611/26635746.html

Form 8-K VSEE HEALTH, INC. For: Jun 02

Thu, 11 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260611/26635746.html

Form 8-K VSEE HEALTH, INC. For: Jun 08

Thu, 11 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260611/26635752.html

Form 8-K VSEE HEALTH, INC. For: Jun 08

Thu, 11 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260611/26635752.html

VSee Health divests lab unit, retires 7% of shares in leadership change

Thu, 11 Jun 2026 08:32:49 -0400

VSee Health Inc. (NASDAQ: VSEE) completed the sale of its laboratory subsidiary VSee Lab to former co-CEO Milton Chen under a stock purchase agreement dated May 31, 2026, the company announced.

Chen transferred 2,870,069 shares of VSee Health common stock back to the company as part of the transaction and assumed responsibility for VSee Lab's remaining liabilities. The returned shares represent approximately 7% of the company's outstanding common stock.

Milton Chen resigned as co-chief executive officer and chairman of the board concurrent with the transaction's closing. Dr. Imoigele Aisiku assumed the roles of sole chief executive officer and chairman of the board.

"This

VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership

Thu, 11 Jun 2026 08:30:00 -0400

HOUSTON, TX / ACCESS Newswire / June 11, 2026 / VSee Health, Inc. (NASDAQ:VSEE) today announced the completion of a transformative strategic transaction that separates the Company from its former laboratory subsidiary, VSee Lab, eliminates a significant block of outstanding shares, and positions VSee Health to focus exclusively on its core telehealth and digital health platform businesses.

Under a Stock Purchase Agreement dated May 31, 2026, VSee Health sold 100% of VSee Lab, Inc. to former Co-Chief Executive Officer and Chairman Milton Chen. In connection with the transaction, Mr. Chen transferred all 2,870,069

VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership

Thu, 11 Jun 2026 08:30:00 -0400

Form 424B3 VSEE HEALTH, INC.

Wed, 10 Jun 2026 15:04:00 -0400

si-local-file:///var/storage/secattach/20260610/26629481.html

Form 424B3 VSEE HEALTH, INC.

Wed, 10 Jun 2026 15:04:00 -0400

si-local-file:///var/storage/secattach/20260610/26629481.html

Form 8-K VSEE HEALTH, INC. For: May 31

Fri, 05 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260605/26611243.html

Form 8-K VSEE HEALTH, INC. For: May 31

Fri, 05 Jun 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260605/26611243.html

Form 4 VSEE HEALTH, INC. For: May 31 Filed by: CHEN MILTON

Tue, 02 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260602/26591865.html

Form 4 VSEE HEALTH, INC. For: May 31 Filed by: CHEN MILTON

Tue, 02 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260602/26591865.html

Form 424B3 VSEE HEALTH, INC.

Fri, 29 May 2026 13:52:00 -0400

si-local-file:///var/storage/secattach/20260529/26573380.html

Form 424B3 VSEE HEALTH, INC.

Fri, 29 May 2026 13:52:00 -0400

si-local-file:///var/storage/secattach/20260529/26573380.html

Form 10-Q VSEE HEALTH, INC. For: Mar 31

Fri, 15 May 2026 15:21:00 -0400

si-local-file:///var/storage/secattach/20260515/26504209.html